You are browsing in:
Tag: oclacitinib
Dog scratching_2

A randomised controlled trial testing the rebound-preventing benefit of four days of prednisolone during the induction of oclacitinib therapy in dogs with atopic dermatitis

Olivry, T., Lokianskiene, V., Blanco, A., Mestre, P.D., Bergvall,K. and Beco, L. | Veterinary Dermatology | November 2022
The aim of this randomised controlled trial was to determine whether an initial four-day course of prednisolone at the start of oclacitinib therapy, would reduce pruritus rebound in dogs, one week after decreasing the frequency of oclacitinib administration…

Cat scratching his chin

A double‐blinded, randomized, methylprednisolone‐controlled study on the efficacy of oclacitinib in the management of pruritus in cats with nonflea nonfood‐induced hypersensitivity dermatitis

c. Noli, I. Matricoti and C. Schievano | Veterinary Dermatology | January 2019
The aim of this randomised, double blind methylprednisolone-controlled study was to evaluate the effectiveness and safety of oclacitinib given at 1 mg/kg per os twice daily in cats with non-flea, non-food-induced hypersensitivity dermatitis (NFNFIHD)…